Figure4.
APO866 reduces PARP-1 and SIRT-l activity in myeloma cells. The indicated MM cell lines were treated with APO866 (2.5 or 5 nmol/L) for 48 hours and then subjected to PARP-1 (A) or SIRT-1 (B) enzymatic activity assay.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.